BOLT NASDAQ
Bolt Biotherapeutics, Inc.
1W: -3.6%
1M: -10.2%
3M: -14.0%
YTD: -40.4%
1Y: -39.0%
3Y: -82.9%
5Y: -98.7%
$3.45
-0.06 (-1.71%)
Weekly Expected Move ±9.3%
$3
$3
$3
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2022-01-25
Earliest Filing
2022-01-25
Latest Filing
supplier: 1
Counterparties (Filed by BOLT)
1 relationshipsCompanies named in BOLT's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| EirGenix, Inc. | — | supplier | Amended supply agreement for bulk drug substance EG12014 to manufacture BDC-1001 HER2 Boltbody ISAC | 2022-01-25 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-11 | Earnings Release; Exhibits | View | |
| 2026-06-11 | Shareholder Vote | View | |
| 2026-05-12 | Earnings Release; Exhibits | View | |
| 2026-03-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-02 | Costs Associated with Exit or Disposal Activities; Other Events | View | |
| 2025-08-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-06 | Notice of Delisting or Transfer; Amendments to Articles of Incorporation or Bylaws | View | |
| 2025-06-04 | Other Events | View | |
| 2025-05-28 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-16 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2025-03-24 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-03 | Notice of Delisting or Transfer | View | |
| 2024-12-23 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-09-04 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-07-03 | Notice of Delisting or Transfer | View | |
| 2024-06-14 | Submission of Matters to a Vote of Security Holders | View | |
| 2024-05-14 | Completion of Acquisition or Disposition of Assets; Costs Associated with Exit or Disposal Activitie | Acquisition | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR